University of California, San Diego

Big pharma participation in venture capital financing has become increasingly important as other investors hesitate to fund the biopharmaceutical sector based on macroeconomic unease. With even health

A bevy of big venture capital financings have been announced since Labor Day, the official end of summer in the US, led by a $300m series C round for Acelyrin, Inc. The boom in VC mega-deals is rema

Mydecine, JHU Expand Pact Focused Initially On Smoking Cessation Mydecine Innovations Group Inc. and Johns Hopkins University said on 18 August that they will undertake a five-year collaboration t

Four new sources of venture capital for biotechnology companies were announced during the first half of May with more than $1.7bn in fresh funding for start-ups and growing early-stage firms. Abingwor